CNR2 and neurodegenerative disease: This work provides support for future studies to identify HIV and ART-associated factors leading to alterations in CB1 and CB2 in the brain, as well as a better understanding of the potential ameliorative role of ECS targeting therapies for PWH and other neurodegenerative diseases.